Ledger.Open graph →
SEC Form D · Amendment · filed August 30, 2012

INTARCIA THERAPEUTICS, INC

Offering
$47.5M
Sold
$45.8M
Exemption
Industry
Pharmaceuticals
Location
HAYWARD, CA
Type

People & firms on this filing (22)

Michelle Baron · Hayward, CAExecDavid J. Franklin · Hayward, CAExecGlen Sato · Palo Alto, CADirectorBarbara G. Mcclung · Hayward, CAExecKurt Graves · Hayward, CAExec · DirectorBryan E. Roberts · Palo Alto, CADirectorJames Niedel · New York, NYDirectorIrwin Scher · Gaithersburg, MDDirectorJames M. Ahlers · Hayward, CAExecThomas R. Alessi · Hayward, CAExecEd Mathers · Chevy Chase, MDDirectorMartin Byrne · Grand Cayman, Cayman IslandsExecAcp Offshore General Partner Ii, Ltd · GRAND CAYMAN, Cayman IslandsExecDoug Burton · Orinda, CADirectorRobert C. Lewis · Atlanta, GAExecAndrew D. Africk · Atlanta, GADirectorBrookfield Investment Management Inc · New York, NYDirectorJeremy Rowland · CRESTONE, COExecPhilippe R. Chambon · New Haven, CTDirectorMarc N. Lampert · San Francisco, CADirectorOleg Nodelman · San Francisco, CAExec · DirectorKevin Reilley · Los Altos, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗